Jefferies Financial Group Inc. Fulcrum Therapeutics, Inc. Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.98 - $9.31 $1.68 Million - $2.62 Million	281,590 Added 24.45%	1,433,316 $8.89 Million
Q1 2024 May 13, 2024	SELL	$6.7 - $12.0 $1.89 Million - $3.38 Million	-281,590 Reduced 19.65%	1,151,726 $10.9 Million
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $4.66 Million - $8.71 Million	1,433,316 New	1,433,316 $6.36 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.